AbbVie raises FY19 adj. EPS view to $8.73-$8.83 from $8.65-$8.75
FY19 consensus $8.69. The company’s 2019 adjusted diluted EPS guidance excludes $1.47 per share of intangible asset amortization expense, non-cash charges for contingent consideration adjustments and other specified items.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.